Neo Ivy Capital Management Pacific Biosciences Of California, Inc. Transaction History

Neo Ivy Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$9.97 - $14.05 $587,671 - $828,163	58,944 Added 4405.38%	60,282 $801,000
Q4 2022 Mar 24, 2023	BUY	$5.67 - $11.2 $7,586 - $14,985	1,338 New	1,338 $10,000
Q3 2021 Nov 16, 2021	SELL	$24.86 - $35.02 $127,854 - $180,107	-5,143 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $114,688 - $185,250	5,143 New	5,143 $180,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.